Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Aug 20 2026

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray".

View Attachment

Earlier from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases